Clinical trials
Phase 3 Osteoporosis, Postmenopausal trials in Czechia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2004 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 2 |
| 2019 | 1 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 4 |
| Eli Lilly and Company | 2 |
| Hoffmann-La Roche | 2 |
| Radius Health, Inc. | 2 |
| Alvotech Swiss AG | 1 |
| Enzene Biosciences Ltd. | 1 |
| Fresenius Kabi SwissBioSim GmbH | 1 |
| Gedeon Richter Plc. | 1 |
| Luye Pharma Group Ltd. | 1 |
| Sandoz | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Osteoporosis, Postmenopausal | 18 |
| Bone Diseases, Metabolic | 4 |
| Osteoporosis | 4 |
| Bone Diseases | 2 |
| Fractures, Bone | 2 |
| Musculoskeletal Diseases | 2 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.